Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anne Dyhl-Polk
Inhibitors Targeting CDK4/6, PARP and PI3K in Breast Cancer: A Review
Therapeutic Advances in Medical Oncology
Oncology
Related publications
Treating ER+ Breast Cancer With CDK4/6 Inhibitors
Cancer Discovery
Oncology
CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer
Cancer Discovery
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
Loss of FAT1 Drives Resistance to CDK4/6 Inhibitors in Breast Cancer
Cancer Discovery
Oncology
Targeting CDK4/6 in Patients With Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
More Breast Cancer Patients Could Benefit From PARP Inhibitors
Cancer
Cancer Research
Oncology
Correction: CDK4/6 Inhibitors in the Treatment of Patients With Breast Cancer: Summary of a Multidisciplinary Round-Table Discussion
ESMO Open
Cancer Research
Oncology
PARP Inhibitors in Ovarian Cancer